Proteometabolic analysis in urology


Citar

Texto integral

Resumo

Bibliografia

  1. Льюин Б. Гены. М.: Мир; 1987.
  2. Greene R. A., Jenkins T. M., Wapner R. J. The new genetic era in reproductive medicine: possibilities, probabilities and problems. Int. J. Fertil. Womens Med. 2001; 46 (3): 169-183.
  3. Huson D. H., Reinert K., Kravitz S. A. et al. Design of a compartmentalized shotgun assembler for the human genome. Bioinformatics 2001; 17 (1): 132-139.
  4. Semsarian C., Seidman C. E. Molecular medicine in the 21st century. Intern. Med. J. 2001; 31 (1): 53-59.
  5. Werner Th. Identification and functional modeling of DNA sequence elements of transcription. Briefings in Bioinformat. 2000; 1 (4): 372-380.
  6. Bertram H. C., Eggers N., Eller N. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Analyt. Chem. 2009; 81 (21): 9188-9193.
  7. Crews B., Wikoff W. R., Patti G. J. et al. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomic data. Analyt. Chem. 2009; 81 (20): 8538-8544.
  8. Mello B. P., Abrantes E. F., Torres C. H. et al. No-match ORESTES explored as tumor markers. Nucleic Acids Res. 2009; 37 (8): 2607-2617.
  9. Hortin G. L., Jortani S. A., Ritchie J. C. Jr. et al. Proteomics: a new diagnostic frontier! Clin. Chem. 2006; 52 (7): 1218-1222.
  10. Khan A., Packer N. H. Simple urinary sample preparation for proteomic analysis. J. Proteome Res. 2006; 5 (10: 2824-2838.
  11. Lee S. W., Lee K. I., Kim J. Y. Revealing urologic diseases by proteomic techniques. J. Chromatogr. Analyt. Technol. Biomed. Life Sci. 2005; 5; 203-213.
  12. Nelson P. S., Clegg N., Eroglu B., Hawkins V. The prostate expression database (PEDB): status and enhancements in 2000. Nucleic Acids Res. 2000; 28 (1): 212-213.
  13. Cazares L. H., Adam B. L., Ward M. D. , Nasim S. Normal, benign, preneoplastic and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorptiob/ionization mass spectrometry. Clin. Cancer Res. 2002; 8: 2541-2552.
  14. Чугунов А. Полет бабочки, или немного о пользе структурной геномики. Наука и жизнь 2010; 1: 22-29.
  15. M'Koma A. E., Blum D. L., Norris J. L. et al. Detection of preneoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem. Biophys. Res. Commun. 2007; 353 (3): 829-834.
  16. Park Y., Downing S. R., Kim D. et al. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data. Bioinformatics. 2007; 23 (12): 1451-1458.
  17. Rehman I., Azzouzi A. R., Catto J. W. et al. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology 2004; 64 (6): 1238-1243.
  18. Wu D. L., Zhang W. H., Wang W. J. et al. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern. Technol. Cancer Res. Treat. 2008; 7 (3): 155-160.
  19. Cayatte C., Pons Q., Guigoins J. M. et al. Protein profiling of rat ventral prostate following chronic finasteride administration: identification and localization of a novel putative androgen-regulated protein. Mol. Cell. Proteomics. 2006; 5 (11): 2031-2043.
  20. Desireddi N. V., Campbell P. L., Stern J. A., Sobkoviak R. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha as possible biomarkers for the chronic pelvic pain syndrome. J. Urol. (Baltimore) 2008; 179 (5): 1857- 1861.
  21. Dutcowski J., Gambin A. On consensus biomarker selection. BMC. Bioinformat. 2007; 8 (5): 5.
  22. Oehr P. Proteomics as a tool for detection of nuclear matrix proteins and new biomarkers for screening of early tumors stage. Anticancer Res. 2003; 23 (2A): 805-812.
  23. Castelli T., Cimino S., Magno C., Morgia G. Molecular markers for prostatic cancer. Front. Biosci. (Elite Ed.) 2010; 1-2: 641- 656.
  24. Chuan Y., Pang S. T., Bergh A., Norstedt G. Androgens induce CD-9 in human prostate tissue. Int. J. Androl 2005; 28 (5): 291-296.
  25. Feldman A. S., Banyard J., Wu C. L. et al. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin. Cancer Res. 2009; 15 (3): 1024-1031.
  26. Kehinde E. O., Maghrebi M. A., Anim J. T. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers. Can. J. Urol. 2008; 15 (2): 3967- 3974.
  27. Pang J., Liu W. P., Liu X. P. et al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. Proteome Res. 2010; 9 (1): 216-226.
  28. Parekh D. J., Ankerst D. P., Troyer D. et al. Biomarkers for Tostate cancer detection. J. Urol. (Baltimore) 2007; 178 (6): 2252-2259.
  29. Ploussard G., de la Taille A. Urine biomarkers in prostate cancer. Nat. Rev. Urol. 2010; 7 (2): 101-109.
  30. Tan L. B., Chen K. T., Yuan Y. C. et al. Identification of urine PLK2 (as a marker of bladder tumors by proteomic analysis. Wld J. Urol. 2010; 28 (1): 117-122.
  31. Максимов В. А. Оптимизация ранней диагностики заболеваний предстательной железы: Автореф. дис. ... д-ра мед. наук. М.; 2009.
  32. Unwin R. D., Knowles N. A., Selby P. J., Banks R. E. Urological malignancies and the proteomic-genomic interface. Electrophoresis 1999; 20 (18): 3629-3637.
  33. Meehan K. L., Holland J., Dawkins H. J. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate 2002; 50 (1): 54-63.
  34. Leiblich A., Cross S. S., Catto J. W. et al. Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. Prostate 2007; 67 (16): 1761-1769.
  35. Xu G., Xiang C. Q., Lu X. et al. Proteomic analysis, in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses. Zhonghua Yi Xue Za Zhi. 2008; 88 (12): 858-860.
  36. Xu G., Xiang C. Q., Lu Y. et al. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett. 2009; 282 (2): 205-213.
  37. Utleg A. G., Yi E. C., Xie T. et al. Proteomic analysis of human prostasomes. Prostate 2003; 56 (2): 150-160.
  38. Poliakov A., Spilman M., Dokland T. et al. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 2009; 69 (2): 159-167.
  39. Lexander H., Franzen B., Hirschberg D. et al. Differential protein expression in anatomical zones of the prostate. Proteomics 2005; 5 (10): 2570-2576.
  40. Canales B. K., Anderson L., Higgins L. et al. Proteomic analysis of a matrix stone: a case report. Urol. Res. 2009; 37 (6): 323- 329.
  41. Chen W. C., Lai C. C., Tsai Y. et al. Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study. J. Clin. Lab. Anal. 2008; 22 (1): 77-85.
  42. Kistler A. D., Mischak H., Poster D. et al. Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009; 76 (1): 89-96.
  43. Пушкарь Д. Ю., Сегал А. С. Хронический простатит: что нас тревожит? Андрол. и генит. хир. 2008; 1: 43-46.
  44. Сагалов А. В. Амбулаторно-поликлиническая андрология: Руководство для врачей. М.: Мед. книга; Н. Новгород: Изд. НГМА; 2006.
  45. Meares Jr. E. M. M. D. Prostatitis and related disorders. In: Walsh: Campbell's urology. 7-th; 1998; vol. 1: 458-486.
  46. Partin A. W., Coffey D. S. The molecular biology, endocrinology and physiology of the prostate and seminal vesicles. In: Walsh: Campbell's urology. 7-th ed., 1998; vol. 2: 1-54.
  47. Kirby R. S., Lowe D., Bultitude M. I., Shuttleworth K. E. D. Intra-prostatic urinary reflux: An aetiological factor in abacterial prostatitis. Br. J. Urol. 1982; 54: 729.
  48. Пятакова Е. И., Каманцева С. М., Беляков Н. Ф. Хронический простатит - болезнь или симптом? В кн.: Материалы конференции "Мужское здоровье" 19-21 нояб. 2003, Москва. М.; 2003. 65.
  49. Хейфец В. Х., Забежинский М. А., Хролович А. Б., Хавинсон В. Х. Экспериментальные модели хронического простатита. Урология 1999; 5: 48-52.
  50. Feeney D. A., Johnston G. R., Osborne C. A., Tomlinson M. J. Maximum-distention retrograde urethrocystography in healthy male dogs: occurrence and radiographic appearance of urethroprostatic reflux. Am. J. Vet. Res. 1984; 45 (5): 948-952.
  51. Rameriz C. T., Ruiz J. A., Gomez A. Z. et al. A crystallographic study of prostatic calculi. J. Urol. (Baltimore) 1980; 124: 840.
  52. Аляев Ю. Г., Винаров А. З., Синицын В. Е. и др. Микционная спиральная томография уретры в диагностике интрапростатического рефлюкса. Андрол. и генит. хир. 2004; 4: 50-51.
  53. Прокоп М., Галански М. Спиральная и многослойная компьютерная томография. М.: МЕДпресс-информ; 2009; т. 2.
  54. Miller L. J., Fischer K. A., Goralnick S. J. et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59 (4): 603-608.
  55. Мазин П. В., Тарасов Н. И. Методологические инновации дигитального скрининга предстательной железы. Урал. мед. журн. 2008; 2 (42): 85-90.
  56. Rahman N. U., Phonsombat S., Bochinski D. et al. An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. Br. J. Urol. Int. 2007; 100 (3): 658-663.
  57. Мазин П. В. Системно-сравнительный метод оценки влияния социальных, климатических и профессиональных факторов на эректильную функцию и состояние предстательной железы у мужчин Кировской области. В кн.: Материалы Межрегиональной науч.-практ. конф. урологов Урала "Актуальные проблемы урологии и андрологии". : Изд. "АБРИС"; 2007. 174-176.
  58. Мазин П. В. Воздействие профессиональных вредностей на эректильную функцию и состояние предстательной железы у мужчин Кировской области. В кн.: Материалы Межрегиональной науч.-практ. конф. урологов Урала "Актуальные проблемы урологии и андрологии". : Изд. "АБРИС"; 2007. 169-171.
  59. Pang S., Levine L., Chow D et al. Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J. Clin. Endocrinol. 1979; 48: 821-826.
  60. Forest M. G. Plasma androgens (testosterone and 4-androstenedione) and 17-hydroxyprogesterone in the prenatal, prepubertal and peripubertal periods in the human and the rat: Differences between species. J. Steroid. Biochem. 1979; 11: 543-548.
  61. Bronson F. H., Whisett M. J., Hamilton T. H. Responsiveness of accessory glands of adult mice to testosterone: priming with neonatal injections. Endocrinology 1972; 90: 10-16.
  62. Chung L. W. K., McFadden D. K. Sex steroid imprinting and prostatic growth. Insvest. Urol. 1980; 17: 337-342.
  63. Naslund M. J., Coffey D. S. The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J. Urol. (Baltimore) 1986; 136 (5): 1136-1140.
  64. Prins G. S., Birch L. The developmental pattern of androgen receptor regulation in the rat prostate lobes is altered following neonatal exposure to estrogen. Endocrinology 1995; 136: 1303-1314.
  65. Денисов А. Б., Пушкарь Д. Ю., Денисов С. А. Использование кристаллогенных свойств слюны для ранней диагностики рака предстательной железы. Бюл. экспер. биол. 2006; 141 (S): 37-40.
  66. Zhang L., Xiao H., Wong D. J. Salivary biomarkers for clinical applications. Mol. Diagn. Ther. 2009; 13 (4): 245-259.
  67. Kerman B. E., Cheshire A. M., Andrew D. J. From fate to function: the Drosophila trachea and salivary gland as models for tubulogenesis. Differentiation 2006; 74 (7): 326-348.
  68. Liao Q., Kleeff J., Xiao Y. et al. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis. Histol. Histopatol. 2003; 18 (2): 425-433.
  69. Денисов А. Б. Микрокристаллизация слюны: новые методические подходы. Стоматология 2007; 60 (5): 20-23.
  70. Foresto P., Bioindi C, Racca L. et al. Abnormal glycosylation of soluble ABH antigens in tumors of the urinary tract. Arch. Esp. Urol. 2000; 53 (3): 196-199.
  71. Mita K., Matsubara A., Usui T. Measurement of salivary testosterone by a simple enzyme immunoassay procedure. Nippon Hinyokika Gakkai Zasshi 2005; 96 (6): 610-616.
  72. Ayatollani H., Darabi Mahboub M. R., Mohammadian N. et al. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men. Urol. J. 2007; 4 (4): 238-241.
  73. Udby L., Calafat J., Sorensen O. E. et al. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J. Leukoc. Biol. 2002; 72 (3): 462-469.
  74. Nishimori I., Kohsaki T., Onishi S. et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern. Med 2007; 46 (24): 1983-1989.
  75. Sänchez-Castanón M., de Las Heras-Castano G., López-Hoyos M. Autoimmune pancreatitis: An underdiagnosed autoimmune disease with clinical, imaging and serological features. Autoimmun. Rev. 2010; 9 (4): 237-240.
  76. Uehara T., Hamano H., Kawakami M. et al. Autoimmune pancreatitis-associated prostatitis: Distinct clinicopathological entity. Pathol. Int. 2008; 58 (2): 118-125.
  77. Frank S. A. Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc. Natl. Acad. Sci. USA 2010; 107 (Suppl. 1): 1725-1730.
  78. Parsons C. L., Albo M. Intravesical potassium sensitivity in patients with prostatitis. J. Urol. (Baltimore) 2002; 168 (3): 1054-1057.
  79. Liang C. Z., Guo Q. K., Hao Z. Y. et al. K-channel expression in prostate epithelium and its implications in men with chronic prostatitis. Br. J. Urol. Int. 2006; 97 (1): 190-192.
  80. Vera P. L., Meyer-Siegler K. L. Inflammation of the rat prostate evokes release of macrophage migration inhibitory factor in the bladder: evidence for a viscerovisceral reflex. J. Urol. (Baltimore) 2004; 172 (6): 2440-2445.
  81. Wang W., Bergh A., Damber J. E. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation. Acta Pathol. Microbiol. Immunol. Scand. 2009; 117 (3): 185-195.
  82. Wang W., Bergh A., Damber J. E. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. Prostate 2007; 67 (11): 1238-1246.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2011

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies